Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 760-769

  Puttfarcken, Pamela S ^a   Manelli, Arlene M ^a   Falduto, Michael T ^a   Getz, Godfrey S ^b   LaDu, Mary Jo ^b  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Hippocampal cultures; Amyloid induced neurotoxicity

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALLELE; ANIMAL CELL; ARTICLE; CELL VIABILITY; DRUG EFFECT; HIPPOCAMPUS; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031013111     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020760.x     Document Type: Article

References (57)

1. Arispe N., Rojas E., and Pollard H. B. (1993) Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad Sci. USA 90, 567-571.
2. Basu S. K., Ho Y. K., Brown M. S., Bilheimer D. W., Anderson R. G. W., and Goldstein J. L. (1982) The biochemical and genetic studies of apoprotein E secreted by mouse macrophages and human monocytes. J. Biol. Chem. 257, 9788-9795.
3. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827.
4. Bellosta S., Nathan B. P., Orth M., Dong L. M., Mahley R. W., and Pitas R. E. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produce differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063-27071.
5. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501-1513.
6. Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J., and Shooter E. M. (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83, 1015-1031.
7. Brewer G. J., Torricelli J. R., Evege E. K., and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
8. Carlsson J., Armstrong V. W., Reiber H., Felgenhauer K., and Seidel D. (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta 196, 167-176.
9. Driscoll D. M. and Getz G. S. (1984) Extrahepatic synthesis of apolipoprotein E. J. Lipid Res. 25, 1368-1379.
10. Elshourbagy N. A., Lia W. S., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA 82, 203-207.
11. Gelman B. B., Rifai N., Christenson R. H., and Silverman L. M. (1988) Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Ann. Clin. Lab. Sci. 18, 46-52.
12. Han S.-H., Hulette C., Saunders A. M., Einstein G., Pericak-Vance M., Strittmatter W. J., Roses A. D., and Schmechel D. E. (1994) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128, 13-26.
13. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
14. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., and Schwartz A. L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92, 9480-9484.
15. Iwatsubo T., Mann D. M., Odaka A., Suzuki N., and Ihara Y. (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37, 294-299.
16. Kimura H. and Schubert D. (1993) Amyloid β protein activates tachykinin receptors and IP3 accumulation by synergy with glutamate. Proc. Natl. Acad. Sci. USA 90, 7508-7512.
17. Koudinov A., Matsubara E., Frangione B., and Ghiso J. (1994) The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem. Biophys. Res. Commun. 205, 1164-1171.
18. Koudinov A. R., Koudinova N. V., Kumar A., Beavis R. C., and Ghiso J. (1996) Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. Biochem. Biophys. Res. Commun. 223, 592-597.
19. Kowal R. C., Herz J., Weisgraber K. H., Mahley R. W., Brown M. S., and Goldstein J. L. (1990) Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265, 10771-10779.
20. Kowall N. W., McKee A. C., Yankner B. A., and Beal M. F. (1992) In vivo neurotoxicity of beta-amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol. Aging 13, 537-542.
21. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403-23406.
22. LaDu M. J., Lukens J. R., Pederson T. M., Reardon C. A., Getz G. S., and Falduto M. T. (1995a) Particle size distribution of native apolipoprotein E in the presence of β-amyloid peptide. Soc. Neurosci. Abstr. 21, 5.
23. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., and Falduto M. T. (1995b) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039-9042.
24. Lalazar A., Weisgraber K. H., Rail S. C., Giladi H., Innerarity T. L., Levanon A. Z., Boyles J. K., Amit B., Gorecki M., Mahley R. W., and Vogel T. (1988) Site-specific mutagenesis of human apolipoprotein E. J. Biol. Chem. 263, 3542-3545.
25. Ma J., Yee A., Brewer H. B., Das S., and Potter H. (1994) Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer α-protein into filaments. Nature 372, 92-94.
26. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
27. Manelli A. M. and Puttfarcken P. S. (1995) β-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Res. Bull. 38, 569-576.
28. Mattson M. T., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
29. Metzger R. E., LaDu M. J., Pan J. B., Getz G. S., Frail D. E., and Falduto M. T. (1996) Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 372-380.
30. Murakami M., Ushio Y., Morino Y., Ohta T., and Matsukado Y. (1988) Immunohistochemical localization of apolipoprotein E in human glial neoplasms. J. Clin. Invest. 82, 177-188.
31. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
32. Naslund J., Thyberg J., Tjernberg L. O., Wernstedt C., Karlstrom A. R., Bogdanovic N., Gandy S. E., Lannfelt L., Terenius L., and Nordstedt C. (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 15, 219-228.
33. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
34. Nathan B. P., Chang K. C. Bellosta S., Brisch E., Ge N., Mahley R. W., and Pitas R. E. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270, 19791-19799.
35. Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367-368.
36. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
37. Pitas R. E., Boyles J. K., Lee S. H., Foss D., and Mahley R. W. (1987a) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148-161.
38. Pitas R. E., Boyles J. K., Lee S. H., Hui D., and Weisgraber K. H. (1987b) Lipoproteins and their receptors in the central nervous system - characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262, 14352-14360.
39. Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
40. Puttfarcken P. S., Manelli A. M., Neilly J., and Frail D. E. (1996) Inhibition of age-induced β-amyloid neurotoxicity in rat hippocampal cells. Exp. Neurol. 138, 73-81.
41. Reardon C. A., Lau Y.-F., Paik Y.-K., Weisgraber K. H., Mahley R. W., and Taylor J. M. (1986) Expression of human apolipoprotein E gene in cultured mammalian cells. J. Biol. Chem. 261, 9858-9864.
42. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
43. Rebeck G. W., Harr S. D., Strickland D. K., and Hyman B. T. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/ low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
44. Sanan D. A., Weisgraber K. H., Russell S. J., Mahley R. W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A. D., and Strittmatter W. J. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest. 94, 860-869.
45. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Cram B., Goldgaber D., and Roses A. D. (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
46. Schmechel D. E., Saunders A. M., Strittmatter W. J., Cram B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., and Roses A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
47. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N., and Li W. Y. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
48. Snipes G. J., McGuire C. B., Norden J. J., and Freeman J. A. (1986) Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc. Natl. Acad. Sci. USA 83, 1130-1134.
49. Snyder S. W., Ladror U. S., Wade W. S., Wang G. T., Barrett L. W., Matayoshi E. D., Huffaker H. J., Krafft G. A., and Holzman T. F. (1994) Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths? Biophys. J. 67, 1216-1228.
50. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993a) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
51. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-speciric effects and implications for late-onset Alzheimer disease Proc. Natl. Acad. Sci. USA 90, 8098-8102.
52. Whitson J. S., Mims M. P., Strittmatter W. J., Yamaki T., Morrisett J. D., and Appel S. H. (1994) Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Commun. 199, 163-170.
53. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
54. Wisniewski T., Lalowski M., Golabek A., Vogel T., and Frangione B. (1995) Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 345, 956-958.
55. Wolf B. B., Beatriz M., Lopes S., VandenBerg S. R., and Gonias S. L. (1992) Characterization and immunohistochemical localization of α2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 141, 37-42.
56. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
57. Zhou Z., Smith J. D., Greengard P., and Gandy S. (1996) Alzheimer amyloid-β peptide forms denaturant-resistant complex with type E3 but not type E4 isoform of native apolipoprotein E. Mol. Med. 2, 175-180.